Financial statements Optimapharm
Balance sheet of Optimapharm
Company age:
Age:
6 y. 2 m. 12 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of OPTIMAPHARM
|
Year
|
2019
|
2020
|
2021
|
2022
|
|---|---|---|---|---|
| Total assets | 55 827,59 | 483 881,75 | 603 337,97 | 1 154 038,48 |
| A. Fixed assets | 0,00 | 0,00 | 0,00 | 0,00 |
| B. Current assets | 55 827,59 | 483 881,75 | 603 337,97 | 1 154 038,48 |
| C. Share capital contributions (basic funds) | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - |
| Total liabilities | 55 827,59 | 483 881,75 | 603 337,97 | 1 154 038,48 |
| A. Equity | -104 236,12 | 17 004,57 | 120 916,31 | 256 523,20 |
| B. Liabilities and provisions for liabilities | 160 063,71 | 466 877,18 | 482 421,66 | 897 515,28 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 160 063,71 | 466 877,18 | 482 421,66 | 807 796,98 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.